Woldu, Solomon
175  results:
Search for persons X
?
1

PRIMARY TUMOR RESPONSE TO PRE-OPERATIVE IMMUNE CHECKPOINT I..:

Bhanvadia, Raj R ; Gerald, Thomas ; Gunenc, Damla...
Urologic Oncology: Seminars and Original Investigations.  42 (2024)  - p. S73 , 2024
 
?
2

Reply to Khurshid R. Ghani's letter to editor regarding the..:

Woldu, Solomon ; Lotan, Yair
Urologic Oncology: Seminars and Original Investigations.  42 (2024)  3 - p. 36 , 2024
 
?
3

Standardization of the evaluation and surveillance of patie..:

Lotan, Yair ; Agarwal, Piyush ; Black, Peter...
Urologic Oncology: Seminars and Original Investigations.  42 (2024)  8 - p. 223-228 , 2024
 
?
4

Testicular Radiomics To Predict Pathology At Time of Postch..:

Venishetty, Nikit ; Taylor, Jacob ; Xi, Yin...
Clinical Genitourinary Cancer.  22 (2024)  1 - p. 33-37 , 2024
 
?
6

SOCIOECONOMIC AND DEMOGRAPHIC DISPARITIES IN IMMUNOTHERAPY ..:

Holland, Levi ; Taylor, Jacob ; Bhanvadia, Raj...
Urologic Oncology: Seminars and Original Investigations.  42 (2024)  - p. S43 , 2024
 
?
7

ONCOLOGIC OUTCOMES OF GEMCITABINE-DOCETAXEL COMBINATION INT..:

Annapureddy, Drupad ; Taylor, Jacob ; Howard, Jeffrey...
Urologic Oncology: Seminars and Original Investigations.  42 (2024)  - p. S52-S53 , 2024
 
?
9

NATURAL HISTORY OF BLADDER-SPARING THERAPY IN PATIENTS WITH..:

Taylor, Jacob ; Annapureddy, Drupad ; Howard, Jeffrey...
Urologic Oncology: Seminars and Original Investigations.  42 (2024)  - p. S49 , 2024
 
?
10

SOCIOECONOMIC AND DEMOGRAPHIC DISPARITIES IN ADMINISTRATION..:

Holland, Levi ; Bhanvadia, Raj R ; Iftach, Jeff...
Urologic Oncology: Seminars and Original Investigations.  42 (2024)  - p. S29-S30 , 2024
 
?
11

First analysis of the safety and efficacy of UGN-101 in the..:

Jacob, Joseph M. ; Woldu, Solomon L. ; Linehan, Jennifer...
Urologic Oncology: Seminars and Original Investigations.  42 (2024)  1 - p. 20.e17-20.e23 , 2024
 
?
13

The ablative effect of mitomycin reverse thermal gel: Expan..:

Kaimakliotis, Hristos Z. ; Tachibana, Isamu ; Woldu, Solomon...
Urologic Oncology: Seminars and Original Investigations.  41 (2023)  9 - p. 387.e1-387.e7 , 2023
 
1-15